Correlation Between Surrozen and Oncternal Therapeutics
Can any of the company-specific risk be diversified away by investing in both Surrozen and Oncternal Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Surrozen and Oncternal Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Surrozen and Oncternal Therapeutics, you can compare the effects of market volatilities on Surrozen and Oncternal Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Surrozen with a short position of Oncternal Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Surrozen and Oncternal Therapeutics.
Diversification Opportunities for Surrozen and Oncternal Therapeutics
-0.38 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Surrozen and Oncternal is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Surrozen and Oncternal Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncternal Therapeutics and Surrozen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Surrozen are associated (or correlated) with Oncternal Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncternal Therapeutics has no effect on the direction of Surrozen i.e., Surrozen and Oncternal Therapeutics go up and down completely randomly.
Pair Corralation between Surrozen and Oncternal Therapeutics
Given the investment horizon of 90 days Surrozen is expected to generate 0.73 times more return on investment than Oncternal Therapeutics. However, Surrozen is 1.38 times less risky than Oncternal Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Oncternal Therapeutics is currently generating about -0.05 per unit of risk. If you would invest 675.00 in Surrozen on August 24, 2024 and sell it today you would earn a total of 255.00 from holding Surrozen or generate 37.78% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Surrozen vs. Oncternal Therapeutics
Performance |
| Timeline |
| Surrozen |
| Oncternal Therapeutics |
Surrozen and Oncternal Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Surrozen and Oncternal Therapeutics
The main advantage of trading using opposite Surrozen and Oncternal Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Surrozen position performs unexpectedly, Oncternal Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncternal Therapeutics will offset losses from the drop in Oncternal Therapeutics' long position.| Surrozen vs. Lyra Therapeutics | Surrozen vs. Hookipa Pharma | Surrozen vs. Cingulate Warrants | Surrozen vs. SAB Biotherapeutics |
| Oncternal Therapeutics vs. Lyra Therapeutics | Oncternal Therapeutics vs. Hookipa Pharma | Oncternal Therapeutics vs. Cingulate Warrants | Oncternal Therapeutics vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |